The World Health Organisation (WHO) has announced a “temporary pause” in its solidarity trial on the use of hydroxychloroquine for treatment of COVID-19 patients.
Tedros Ghebreyesus, the WHO director-general, made the announcement at a media briefing on Monday.
He cited the study published by The Lancet, which had examined the effects of the use of hydroxychloroquine alone or when used with a macrolide, and reported a higher mortality rate.
